# FDA Inspection 840827 - Biomat USA Inc - July 12, 2013

Source: https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/f0f10727-e70a-406d-bce3-b1cb031bd915
Source feed: FDA_Inspections

> FDA Inspection 840827 for Biomat USA Inc on July 12, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 840827
- Company Name: Biomat USA Inc
- Inspection Date: 2013-07-12
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1106611 - 2019-09-12](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/df48ec55-4721-464f-80d8-592a249ae887)
- [FDA Inspection 980034 - 2016-07-27](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/fe16ad4e-6d44-42cc-b65a-bb331e3b5796)
- [FDA Inspection 695746 - 2010-10-20](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/8dac6e73-adac-42c6-b7c3-cc5afcaeb862)

Company: https://www.globalkeysolutions.net/companies/biomat-usa-inc/dc47ba7b-927d-4c93-80f9-71f35579f6bb

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d